Browse the evidence

In typical obesity, elevated leptin levels fail to suppress appetite or increase energy expenditure due to leptin resistance, and high-fat diets can exacerbate this resistance.

In common obesity, your body produces high levels of leptin, but your brain stops listening to it. This is called leptin resistance. It means you won't feel full or burn more energy just because you have more fat tissue. High-fat diets can make this resistance worse.

Aging, estrogen deficiency, glucocorticoid treatment, and disuse stimulate the accumulation of intramyocellular lipid and intermuscular fat (myosteatosis), which is linked to loss of muscle strength, reduced insulin sensitivity, and increased mortality.

As you age, your muscles are prone to accumulating fat, which weakens them and increases your risk of falls. This process is driven by hormonal changes and lack of use. To counteract this, engage in regular resistance exercise or low-magnitude vibration to keep your muscle cells from turning into fat cells.

Low insulin-stimulated glucose disposal (M) and low acute insulin secretory response (AIR) are independent and additive predictors of the progression from normal glucose tolerance (NGT) to impaired glucose tolerance (IGT) and from IGT to type 2 diabetes.

If you have normal or pre-diabetic blood sugar, your body's ability to use insulin (sensitivity) and its ability to release insulin quickly (secretion) are the two main levers determining if you develop diabetes. Both matter equally at every stage. Monitoring these metrics can help identify high-risk individuals for early intervention.

Upper body subcutaneous fat is the primary source of excess free fatty acid (FFA) release in upper body obesity, contributing more to systemic FFA levels and metabolic risk than visceral fat itself.

When addressing upper body obesity, recognize that subcutaneous fat in the abdominal area is a major contributor to metabolic issues by releasing fatty acids into the bloodstream. Strategies to improve metabolic health should consider this specific fat depot's behavior.

Elevated free fatty acid (FFA) delivery to the liver from visceral and upper body subcutaneous fat depots stimulates hepatic VLDL-triglyceride production, leading to hypertriglyceridemia and low HDL cholesterol, which are independent risk factors for cardiovascular disease.

High levels of fatty acids reaching the liver from abdominal fat stores drive the production of triglyceride-rich lipoproteins, increasing cardiovascular risk. Managing abdominal fat can help mitigate this risk.

Glucose and its metabolites (e.g., lactate, alanine, TCA intermediates) act as signaling molecules that communicate the metabolic status of peripheral tissues (muscle, adipose) to other organs (liver, hypothalamus) to maintain glucose homeostasis.

Your body uses the byproducts of glucose metabolism (like lactate and alanine) to talk to your liver and brain about your energy status. This 'intertissue communication' helps regulate blood sugar. Disruptions in this signaling, such as reduced glucose entry into fat cells, can lead to insulin resistance.

Black adults experience higher rates of short sleep and poor sleep quality compared to Whites, and this disparity is exacerbated by socioeconomic stressors and unique psychosocial stressors like 'John Henryism'.

If you are Black, you may face unique stressors that disrupt sleep. Recognize that your sleep difficulties may be linked to systemic stress and not just personal habits. Seek support for stress management and prioritize rest as a health necessity.

Pharmacological interventions for diabetes prevention are effective during active treatment but lose their efficacy immediately upon discontinuation, indicating they do not alter the underlying pathophysiology of insulin resistance or beta-cell dysfunction.

Medications can effectively prevent diabetes while you are taking them, but they do not provide long-term protection once you stop. If you discontinue medication, your risk returns to baseline. Therefore, medications are not a substitute for sustainable lifestyle changes if you plan to stop treatment.

In healthy individuals, chronological age itself does not cause insulin resistance; observed declines in insulin sensitivity with age are fully explained by age-related increases in body mass index (BMI) and fat mass.

Do not accept insulin resistance as an inevitable part of aging. This study shows that in healthy people, the decline in insulin sensitivity is actually driven by gaining weight (specifically fat mass) and changes in body composition, not age itself. Focus on maintaining a healthy BMI and body composition rather than blaming your age for metabolic changes.

In lean women, insulin action declines with age specifically due to impaired suppression of free fatty acids (FFAs), which leads to substrate competition where FFAs are oxidized instead of glucose.

If you are a lean woman, be aware that your insulin sensitivity may decline with age due to how your body handles fat acids, not just weight gain. This is a specific biological mechanism (substrate competition) rather than just 'getting old'. Monitoring body composition and metabolic health is important even if your BMI remains low.

Peripheral nutrient sensing mechanisms (taste, gut hormones like GLP-1, PYY, CCK, and signals from adipose tissue like leptin) provide critical feedback to the brain to regulate food intake and energy expenditure.

Understanding that hormones like GLP-1, PYY, and leptin signal satiety and energy status can help explain why certain foods (high fat/protein) trigger stronger satiety signals than others. Prioritizing foods that naturally stimulate these peripheral sensors (e.g., protein, fiber) may support natural homeostatic regulation.

Hypothalamic integration of nutritional information via neuropeptides (NPY/AgRP and POMC/CART) and molecular sensors (AMPK, mTOR) is a critical hub for regulating energy balance, with genetic defects in these pathways causing severe obesity.

Genetic factors play a significant role in how the brain regulates hunger and satiety. For some, this regulation is impaired due to genetic defects (e.g., MC4R deficiency). This highlights that obesity is not always a simple lifestyle choice but can have strong biological underpinnings.

Adenosine acts as a primary sleep-promoting factor by inhibiting wake-active cholinergic neurons in the basal forebrain via A1 receptors and stimulating sleep-active neurons in the ventrolateral preoptic area (VLPO) via A2 receptors, with extracellular concentrations increasing during wakefulness and decreasing during sleep.

Your brain naturally produces adenosine during wakefulness, which builds up to create sleep pressure. This process is mediated by specific receptors in the basal forebrain and VLPO. While caffeine blocks this signal to keep you awake, understanding this mechanism explains why sleep deprivation leads to higher adenosine levels and why sleep is necessary to clear it.

Gastric distension and gut hormones (CCK, GLP-1, PYY) are the primary physiological mechanisms for satiation and satiety, but these signals can be overridden by hedonic and external factors.

Understand that your body has sophisticated satiety signals (gastric distension, CCK, GLP-1, PYY) that work to stop eating. However, in an environment with highly palatable, energy-dense foods, these signals are often overridden by reward pathways. To manage weight, you must account for this override by controlling portion sizes and food availability, rather than relying solely on internal fullness cues.

Adiposity signals, specifically leptin and insulin, act as afferent information to the brain to regulate long-term body fat levels by modulating the sensitivity of meal-terminating signals.

Your body uses leptin and insulin to tell your brain how much fat you have. When you lose weight, these signals drop, making you less sensitive to fullness cues and driving you to eat more. This is a biological defense mechanism, not a character flaw. Recognizing this helps reduce guilt and allows for more sustainable, long-term strategies that respect these biological signals.

Accelerometer-derived measures of sleep duration and quality are heritable and genetically distinct from self-reported measures, with specific genetic variants (e.g., PDE11A, MEIS1) influencing sleep traits.

Use objective sleep tracking (accelerometers) to get a more accurate picture of your sleep genetics and quality, as self-reports may be biased. Focus on identifying specific sleep issues (duration, efficiency) rather than just feeling rested.

Obesity causes hypertension through multiple mechanisms including SNS overactivation, RAAS stimulation, leptin resistance, insulin resistance, and mechanical renal compression.

High blood pressure in obese individuals is not just about volume; it's driven by overactive nerves, hormones like leptin and insulin, and physical pressure on the kidneys. Treating the obesity addresses these root causes.

Activation of pro-opiomelanocortin (POMC) neurons in the arcuate nucleus suppresses food intake and increases energy expenditure via the central melanocortin pathway.

Your body uses specific brain neurons (POMC) to tell you when to stop eating and burn energy. These neurons respond to hormones like leptin. Understanding this biology helps explain why dieting is hard—it's not just willpower, it's a biological circuit.

Activation of neuropeptide Y/agouti-related peptide (NPY/AgRP) neurons increases food intake primarily by releasing GABA to inhibit anorexigenic centers.

Your brain has 'hunger neurons' (NPY/AgRP) that actively suppress 'fullness' signals by releasing GABA. This biological drive is a primary regulator of food intake.

Genetic variants that increase body fat percentage (BF%) have distinct, locus-specific effects on cardiometabolic disease risk, meaning that increased adiposity does not uniformly increase disease risk and can sometimes be protective depending on the genetic mechanism.

Your body fat percentage alone is not a perfect predictor of your metabolic health. Your genetics influence how that fat affects your risk for diabetes and heart disease. Some genetic profiles that lead to higher body fat may actually be protective against certain metabolic issues, while others may increase risk. Focus on overall metabolic markers (like blood pressure, lipids, and blood sugar) rather than just body fat percentage to assess health.

Macrophage accumulation and polarization towards a proinflammatory (M1-like) state in adipose tissue is the dominant mechanism driving insulin resistance in obesity.

Your fat cells aren't just storage; they recruit immune cells called macrophages when overfilled. These macrophages release inflammatory signals that block insulin. Reducing this inflammation, potentially through weight loss or anti-inflammatory strategies, is crucial for fixing insulin resistance.

Increased adiposity (BMI) within the normal to overweight range (non-obese) causally alters the systemic metabolite profile, adversely affecting cardiometabolic risk markers including lipoprotein subclasses, amino acids, and inflammatory markers.

If you are in your 20s or 30s and your BMI is in the overweight range (even if not obese), your body's metabolic chemistry is likely already shifting in ways that increase long-term health risks. This isn't just about weight; it's about how your body processes fats and sugars. Maintaining a healthy weight now can prevent these metabolic shifts from becoming entrenched.

Reducing dietary saturated fatty acid intake leads to a stepwise increase in plasma Lipoprotein(a) [Lp(a)] concentrations.

Be aware that significantly lowering saturated fat can raise Lipoprotein(a), a specific cardiovascular risk factor. If you have high Lp(a), discuss this trade-off with your doctor when making dietary changes.

Leptin acts as an anorexigenic signal by binding to LEPRb in the hypothalamus, activating the JAK2/STAT3 and PI3K pathways to stimulate POMC and inhibit AgRP neurons, thereby reducing food intake and increasing energy expenditure.

Your body produces leptin to tell your brain you are full. In obesity, this signal often gets ignored (leptin resistance). You cannot simply 'take' leptin to fix this. Focus on strategies that may improve insulin sensitivity and reduce inflammation, which are linked to leptin signaling, rather than seeking leptin-based supplements which are ineffective for most.